Aperio Group’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Aperio Group’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-161	Closed	–	–	2860
2019 Q2	$0	Buy	+161	New	+$221	﹤0.01%	3053

Other funds holding ISEE

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Aperio Group's ISEE Position: Q3 2019 in Review

Aperio Group sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2019, closing a stake of 161 shares.

Aperio Group first reported a position in ISEE in Q2 2019 and held it in 1 quarter. The position peaked at $0 in Q2 2019. 48 funds tracked by Wall St. Rank hold ISEE as of Q3 2019.

Aperio Group reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Aperio Group sold 161 IVERIC bio, Inc. Common Stock shares in Q3 2019.
Aperio Group first reported a position in IVERIC bio, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
Aperio Group's IVERIC bio, Inc. Common Stock position peaked at $0 in Q2 2019.
48 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2019.

Based on Aperio Group's 13F filing for Q3 2019, filed 6 Nov 2019.